Molecular Diagnostics

Cyted Health US Laboratory Earns CAP Accreditation

The gastrointestinal molecular diagnostics company’s facility adds College of American Pathologists accreditation to its existing CLIA certification.

Molecular Diagnostics

Singular Genomics Unveils Direct-Seq Technology for In Situ Sequencing of FFPE Samples

Singular Genomics introduced Direct-Seq technology for in situ sequencing of FFPE samples on its G4X platform and announced the SPOT-Met colorectal cancer study at AGBT 2026, analyzing 1,000 tumors using spatial multiomics.

Molecular Diagnostics

Study Finds Undiagnosed Tuberculosis DNA in US Patients Using Ultrasensitive Test

A Boston University study found TB DNA in 12% to 16% of respiratory samples from hospitalized patients in a low-incidence area using an ultrasensitive assay, suggesting underdiagnosis of tuberculosis in the US.

City of Hope to Evaluate Quest Diagnostics Blood Test for Cancer Monitoring

Apr 22, 2026 | Cancer, Molecular Diagnostics

City of Hope will evaluate Quest Diagnostics’ Haystack MRD liquid biopsy in a multi-year trial, assessing its use for monitoring breast, colorectal, ovarian, and prostate cancers in about 500 patients across 14 US sites.

Genomics Study Identifies 100 Genetic Causes of Vision Loss

Apr 22, 2026 | Molecular Diagnostics

A national study in Abu Dhabi used data from 500,000 citizens to improve early detection and prevention of inherited eye diseases.

Ultima Genomics Presents New Data for Cancer Detection Technology at AACR 2026

Apr 22, 2026 | Cancer, Molecular Diagnostics

Ultima Genomics presented data at AACR 2026 showing its ppmSeq technology detected circulating tumor DNA at low single-digit parts-per-million in a TRACERx pilot of 50 plasma samples.

FDA Grants Breakthrough Status to Liquid Biopsy for Liver Cancer Monitoring

Apr 22, 2026 | Cancer, Company News, Molecular Diagnostics

TCM Biotech has received FDA Breakthrough Device Designation for CatCHimera, a liquid biopsy platform for monitoring minimal residual disease in hepatocellular carcinoma using HBV–host genome integration biomarkers.

Blood Test Shows Promise for Detecting Glioblastoma Using microRNA Signatures

Apr 22, 2026 | Cancer, Molecular Diagnostics

A study identified microRNA patterns in blood plasma that could support noninvasive diagnosis and monitoring of the most aggressive form of brain cancer.

Optical Genome Mapping Catches Missed Genetic Variants in Nearly 20% of Acute Leukemia Cases

Apr 21, 2026 | Leukemia, Molecular Diagnostics

Optical genome mapping detected clinically significant genetic variants missed by standard tests in nearly 20% of acute leukemia cases, according to a 200-patient study.

Seegene Introduces New Data Platform and Automated PCR System

Apr 20, 2026 | Analytical Software Systems, Lab Automation, Molecular Diagnostics

Seegene unveiled its STAgora real-time data analytics platform and an updated CURECA automated PCR system at ESCMID Global 2026, aiming to enhance infectious disease monitoring through integrated laboratory workflows and aggregated test data.

Genome Detective Unveils Automated Pathogen Genomics Platform

Apr 20, 2026 | Analytical Software Systems, Microbiology, Molecular Diagnostics

The cloud-based system aims to address the bottleneck of translating raw genomic data into actionable information for clinical laboratories.

QuidelOrtho Completes Acquisition of LEX Diagnostics and Molecular Testing Platform

Apr 20, 2026 | Company News, Molecular Diagnostic Analyzers

The $100 million deal brings an ultra-fast system for respiratory viruses to QuidelOrtho’s point-of-care portfolio.

Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test

Apr 17, 2026 | Colorectal, Molecular Diagnostics

The Idylla CDx MSI Test detects microsatellite instability in colorectal cancer tissue in under three hours, supporting therapy selection for eligible patients.

CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials

Apr 17, 2026 | Cancer, Lung Cancer, Molecular Diagnostics

CellCarta has secured exclusive global rights to deploy Biofidelity’s Aspyre Lung assay in lung cancer clinical trials, streamlining genomic testing for trial sponsors and reducing reliance on multiple vendors.

Seed Funding to Advance Biopsy Catchment Technology and Liquid Specimen Biorepository

Apr 17, 2026 | Anatomic Pathology, Cancer, Molecular Diagnostics

A $4 million financing round will support development of a liquid specimen biorepository and expand biopsy catchment pilot programs at medical institutions across the US.